What does this article add?
The independent predictors of overall survival were SATI and VATI,
whereas only SMI was determined as independent factor in predicting
progression free survival in mRCC treated with targeted therapy. We for
the first time evaluated a wide range of VBC parameters and sarcopenia
indicators in one cohort.